Floisand Y, Schroeder MA, Chevallier P, Selleslag D, et al. A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment
of steroid-refractory intestinal acute graft-versus-host disease. Bone Marrow Transplant 2021 Jun 9. pii: 10.1038/s41409-021-01356.
PMID: 34108672